Excellent point by Drano “this is the method. Spread a

New Post Public Reply Private Reply Replies (1) Message Board
Mo Drano #70053
1,253
Excellent point by Drano “this is the method. Spread a lie, get jumpy shareholders to sell, and then, if the clinical trial results are good, well, they were able to get rid of some shareholders who won't buy in again.”

Excellent point by 4kids “I never focus on the PPS, that is how NR (non retail) and CEs (colluding entities) prey on retail investors”

Let me attempt to tie these 2 important points together. Look at yesterday’s trading where a supposed 1.58M shares were traded within a 2 cent range and the opening share price (SP) and closing share price was not within a penny or even a tenth of a penny but exactly the same one hundredth of a penny at .3036. Anyone paying attention to this statistical impossibility knew that this was simply an in-your-face market manipulation. Then today’s trading with similar B.S. and around noon there were 560k shares traded with minimal SP movement. In the last couple hours or so “volume” spiked to end at 3.39M shares and SP got slammed by over 4 cents. IMO if there has been any news that has leaked (not from IPIX itself) it is most likely positive news and possibly stellar news. Why would SP go down on upcoming good news? Because the criminals (Non Retail or NR) control IPIX SP and they are significantly upside-down on IPIX.

There are numerous milestones that I believe IPIX will achieve in the next few months and I do not want to minimize any of them including:

- B-IBD UC Phase 2 projected start date
- Rutgers RBL Brilacidin inflammation PR and/or Preprint
- Detailed DoD presentation that was to be given at military symposium
- EUA for B-CV19 from US and/or other country
- B-CV19 Phase 3 initiation
- Development of inhaler and/or depo delivery for B-CV19
- Key additions to the IPIX BOD
- Up List off of the corrupt OTX

…….but there are 2 very key milestones that will allow the above to take place and catapult IPIX to success which in turn will have a huge long term impact on IPIX SP. These 2 milestones are:

1) Successful B-CV19 trial results.
2) Funding (grants and/or partnerships).

Once these 2 key milestones take place there is absolutely no chance for any entity to stop IPIX’s success. The B-CV19 database lock has most likely taken place and the unbinding and analysis of the trial data is most likely underway by the CRO. Hopefully the CRO will provide the finalized data to IPIX by the end of the month and Leo will PR Top Line Results in early September. This is not a prediction of a timeline. The point is that no one knows the trial result at this point. There could however be agreements being drafted that are contingent on positive trial results which is what most IPIX investors believe will successfully happen.

I have a large group of friends and family that have followed me into investing in IPIX. I have told them all the very same point that 4kids makes which is that IPIX is a milestone investment and IPIX short term SP does not matter. The criminals (NR) will continue to collude to compress IPIX SP until they are no longer able to. IMO the milestones of trial success and funding will put a stake in their heart. (I hate to use this graphic of an analogy but I can’t think of a better one to describe the blood-suckers losing control). There will be a full court press by the criminals between now and Top Line results in the next month or so. The criminals will continue to collude by juggling shares amongst themselves and will most likely continue to dig themselves yet a deeper NSS hole. The criminals will use every FUD tactic in their playbook to try to scare investors into selling and to try to minimize the upside once trial results are indeed successfully announced. The criminals need IPIX investors to sell shares under the $5 range. The criminals need IPIX to become a trading stock vs the current environment of stubborn investors holding tight as they know what they own. Once IPIX share price is over $5 there will be institutional demand for the small biotech that has the first and only Covid-killer. Leading up to this we will see IPIX daily volumes in the 10M+ range and eventually in the 30M+ range once institutional demand kicks in. Every dollar increase in IPIX SP will cost the criminals $300M-$500M. At some point in the future when volume is high enough there will be a massive short squeeze. This cannot take place IMO until institutional investor demand kicks in and volume is in the 20M+ range on a consistent daily basis. In the Short term I am expecting IPIX SP to continue to be artificially compressed and very volatile. The criminals will do their best to condition retail investors to trade and sell their IPIX positions. IMO the pendulum will start to swing after successful trial results and funding are announced. IMO the most significant gains in IPIX SP will take place the end of this year and throughout 2022.



Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 9

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 9

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
New 2027 Jeep Wrangler JL-2A: A Blast from the Past

Updated Category News Views 4

Revisiting a Prized Legacy: The 2027 Jeep Wrangler JL-2A Sometimes, what’s new is really just a nod to what’s old—and nowhere is this more so than with the 2027 Jeep Wrangler JL-2A. In the grand parade of automotive history, Jeep's latest creation is more than just a vehicle; it's a time machine that cruises on its historic lineage while strapping on all the modern...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 8

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating a Legacy: BUILD's Impact on Youth Entrepreneurship

Updated Category News Views 266

BUILD Celebrates 25 Years of Transforming Youth Lives BUILD, a leading nonprofit dedicated to empowering youth from underserved backgrounds, is set to celebrate a remarkable milestone: its 25th anniversary of providing valuable entrepreneurship education. This commemorative event, known as BUILD the Future, will take place on a special night aimed at honoring those who...

Continue Reading
Exploring China's Strategic Planning: A Blueprint for Success

Updated Category News Views 130

Understanding China's Strategic Planning Culture Strategic planning in governance plays a crucial role in shaping the future of nations and cultures. In the case of China, this culture is deeply ingrained in the political fabric, often referred to as part of the Communist Party of China's (CPC) managerial philosophies. The five-year plans initiated by the CPC serve as...

Continue Reading
Huyett Enhances Precision Production with New Swiss Lathes

Updated Category News Views 110

Huyett Expands Manufacturing Capabilities with New Equipment Huyett is thrilled to announce its latest advancement in manufacturing capabilities by adding two state-of-the-art Swiss lathes to its operations. This strategic move aims to bolster the company's ability to produce precision custom fasteners and components, enabling Huyett to deliver high-quality and...

Continue Reading
Tenable to Attend Notable Investor Conferences Soon

Updated Category News Views 108

Tenable to Join Upcoming Investor Events Tenable®, a leader in exposure management, has announced its participation in a series of significant investor events. The company is headed by Amit Yoran, the chairman and CEO, along with Steve Vintz, the CFO. This involvement highlights Tenable's dedication to transparency and fostering strong investor relations. Details of...

Continue Reading
Calamos Launches New Bitcoin ETFs with Downside Protection

Updated Category News Views 230

Calamos' Approach to Bitcoin ETFs Calamos Investments LLC has recently unveiled a set of innovative Bitcoin ETFs that aim to provide both attractive upside potential and robust downside protection. The new funds include the Calamos Bitcoin Structured Alt Protection ETF – October, Calamos Bitcoin 90 Series Structured Alt Protection ETF – October, and Calamos Bitcoin 80...

Continue Reading